Cellectar Biosciences (CLRB) Revenue & Revenue Breakdown
Cellectar Biosciences Revenue Highlights
Cellectar Biosciences Revenue by Period
Cellectar Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | -100.00% |
| 2011-12-31 | $-11.00K | -133.00% |
| 2010-12-31 | $33.33K | -65.39% |
| 2009-12-31 | $96.31K | -23.54% |
| 2008-12-31 | $125.97K | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | -100.00% |
| 2005-12-31 | $12.58K | - |
Cellectar Biosciences generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Cellectar Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $330.37K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | -100.00% |
| 2011-03-31 | $8.33K | -0.01% |
| 2010-12-31 | $8.33K | 0.01% |
| 2010-09-30 | $8.33K | - |
| 2010-06-30 | $8.33K | - |
| 2010-03-31 | $8.33K | -56.89% |
| 2009-12-31 | $19.33K | 41.08% |
| 2009-09-30 | $13.70K | -57.60% |
| 2009-06-30 | $32.31K | 4.34% |
| 2009-03-31 | $30.97K | -15.03% |
| 2008-12-31 | $36.45K | 2.62% |
| 2008-09-30 | $35.51K | -22.25% |
| 2008-06-30 | $45.68K | 448.13% |
| 2008-03-31 | $8.33K | 100.00% |
| 2007-12-31 | - | - |
Cellectar Biosciences generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Cellectar Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CAPR | Capricor Therapeutics | $25.18M | $3.97M |
| BOLT | Bolt Biotherapeutics | $7.88M | $1.27M |
| PULM | Pulmatrix | $7.30M | $1.55M |
| LUMO | Lumos Pharma | $2.05M | $488.00K |
| CBIO | Gyre Therapeutics | $794.00K | - |
| BPTH | Bio-Path | - | - |
| LBPH | Longboard Pharmaceuticals | - | - |
| NXTC | NextCure | - | - |
| BNTC | Benitec Biopharma | - | $6.00K |
| ALRN | Aileron Therapeutics | - | - |
| CLRB | Cellectar Biosciences | - | - |
| MNPR | Monopar Therapeutics | - | - |
| TENX | Tenax Therapeutics | - | - |
| DFFN | CervoMed | - | - |
CLRB Revenue FAQ
What is Cellectar Biosciences’s yearly revenue?
Cellectar Biosciences's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. CLRB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Cellectar Biosciences’s quarterly revenue?
Cellectar Biosciences's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). CLRB's quarterly revenue for Q4 2023 was $330.37K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Cellectar Biosciences’s revenue growth rate?
Cellectar Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.